Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Hemostatic Agents Market From 2025 to 2029?

The market for hemostatic agents has seen robust growth in the past few years. The market size which stands at approximately $4.19 billion in 2024 will escalate to $4.42 billion in 2025, yielding a compound annual growth rate (CAGR) of 5.5%. The past growth in this market can primarily be traced back to the increasing global population age, an upsurge in trauma and accident incidents, a higher frequency of cardiovascular diseases, an escalating number of bleeding conditions like hemophilia, and an increasing patient count suffering from liver diseases and coagulation abnormalities.

In the coming years, robust growth is anticipated for the hemostatic agents market size, predicted to expand to $5.43 billion by 2029 with a CAGR of 5.3%. The surge in market size during the forecast period is linked to the rising number of surgical procedures, the increase in demand for minimally invasive surgeries, growing popularity for orthopedic and aesthetic surgeries, as well as a heightened demand for hemostasis in dental surgery. Key trends for the forecast period encompass progress in hemostatic agent formulas, the appearance of bioengineered and recombinant agents, improved product shelf-life and stability, the creation of combination items, and the invention of synthetic and absorbable hemostats.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Elements Are Contributing To Growth In The Hemostatic Agents Market?

The hemostatic agents market is set to witness increased growth due to the growing number of surgical procedures. These procedures are medical operations conducted by healthcare providers using specialized tools to diagnose, repair or excise body parts for health reasons. The uptick in surgeries is predominantly due to the higher prevalence of chronic diseases, which often necessitate surgical intervention to manage and enhance patient health outcomes. Hemostatic agents play a crucial role during surgical procedures as they expedite the blood clotting process, minimize blood loss and enhance field of view for better precision. For example, reports from the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based professional body, indicate that there was a 102% increase to 31,057 in cosmetic procedures in 2022, compared to the previous year. Furthermore, women accounted for 93% of all these procedures, marking a 101% increase from 2021. As such, the surge in surgical procedures is fuelling the expansion of the hemostatic agents market.

Which Segments Are Detailed In The Global Hemostatic Agents Market Report?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Which Emerging Trends And Strategic Shifts Are Shaping The Hemostatic Agents Market?

Leading organizations in the hemostatic agents market are investing in the creation of cutting-edge solutions like collagen-based hemostats aimed at providing swift, efficient hemostasis and tissue sealing for both minimally invasive and traditional surgeries. Collagen-based hemostats, composed from purified collagen, are used to facilitate blood clotting at injury or surgical incision locations by amplifying the body’s inherent clotting mechanism. For example, in March 2025, Baxter, a healthcare firm based in the US, introduced its product, HEMOPATCH Sealing Hemostat, a pad that can be absorbed and is made from collagen. This advanced pad features a dual-action approach that merges a collagen matrix with a NHS-PEG layer that transforms into a hydrogel when it contacts moisture, causing bleeding sites to seal immediately. The pad firmly adheres to moist tissues, making it apt for both minimally invasive and traditional surgeries where other hemostats may not work as effectively. The patch achieves hemostasis in less than two minutes and it does not require temperature-dependent storage or special setup, simplifying the surgical process. It also disintegrates naturally in the body between six and eight weeks and can be kept at room temperature for as long as three years, fulfilling key clinical and storage prerequisites.

Who Are The Key Contributors To Growth In The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

Which Region Is Projected To Lead The Hemostatic Agents Market By 2025?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model